First Eagle Value in Biotechnology Fund (QP), LP is a hedge fund based in New York, New York. According to its most recent Form D, filed Mar 13, 2018, the fund has sold $68,150,000 of interests to 65 investors since its first sale in Sep 2005. The minimum investment it accepts from an outside investor is $1,000,000. It relies on the Section 3(c)(1) exclusion, which limits it to 100 beneficial owners, typically accredited investors. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include First Eagle Investment Management, LLC.
Performance
No returns have been reported for this fund. Hedge fund returns are not part of SEC filings; managers report them to AltMountain directly.
Is this your fund? Report your monthly returns · How performance works
- Total raised
- $68,150,000Cumulative sales reported on Form D
- Investors
- 65
- First sale
- Sep 15, 2005
- Minimum investment
- $1,000,000
- Who can invest
- Accredited investorsSection 3(c)(1): up to 100 beneficial owners
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- First Eagle Investment Management, LLC
- Latest Form D
- Mar 13, 2018
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Raise history
| Filed | Filing | Total raised | Investors | Source |
|---|---|---|---|---|
| Mar 13, 2018 | Form D/A (amendment) | $68,150,000 | 65 | SEC.gov ↗ |
| Mar 13, 2017 | Form D/A (amendment) | $68,150,000 | 65 | SEC.gov ↗ |
| Mar 14, 2016 | Form D/A (amendment) | $52,700,000 | 65 | SEC.gov ↗ |
| Mar 12, 2015 | Form D/A (amendment) | $52,700,000 | 65 | SEC.gov ↗ |
| Mar 12, 2014 | Form D/A (amendment) | $52,700,000 | 65 | SEC.gov ↗ |
| Mar 12, 2012 | Form D/A (amendment) | $48,450,000 | 63 | SEC.gov ↗ |
6 Form D filings in the SEC's electronic records (2008 onward), the earliest on Mar 12, 2012. Each filing reports the cumulative amount sold and the number of investors to that date, as the fund filed it. Not verified, and not the fund's current assets. Source: U.S. Securities and Exchange Commission, Form D data sets.
Related vehicles with the same name (2)
| Vehicle | Total raised | Investors | Latest Form D |
|---|---|---|---|
| First Eagle Value in Biotechnology Fund (QP), LP (this page) | $68,150,000 | 65 | Mar 13, 2018 |
| FIRST EAGLE VALUE IN BIOTECHNOLOGY OFFSHORE FUND LTD | $3,471,898 | 1 | Sep 20, 2013 |
Funds are often offered through several legal vehicles, such as onshore, offshore, feeder, parallel or tax-exempt versions, and each one files its own Form D. These 2 filings share this fund's name apart from such vehicle words or a series letter, which usually means they are versions of one fund. Grouped by AltMountain from the names on the filings alone, so the list may be incomplete or include a separate fund with a near-identical name; amounts are each vehicle's own filing and should not be added together, because a feeder's money can also be counted in its master fund. Source: SEC Form D filings.
Questions about First Eagle Value in Biotechnology Fund (QP), LP
What is the minimum investment for First Eagle Value in Biotechnology Fund (QP), LP?
According to its latest Form D, filed Mar 13, 2018, the minimum investment First Eagle Value in Biotechnology Fund (QP), LP accepts from an outside investor is $1,000,000.
Who can invest in First Eagle Value in Biotechnology Fund (QP), LP?
First Eagle Value in Biotechnology Fund (QP), LP is generally open only to accredited investors, and it may have no more than 100 beneficial owners because it relies on Section 3(c)(1). It uses Rule 506(b), which does not allow general advertising.
How much has First Eagle Value in Biotechnology Fund (QP), LP raised?
First Eagle Value in Biotechnology Fund (QP), LP reports $68,150,000 sold from 65 investors on its Form D filed Mar 13, 2018. This is cumulative sales since the offering began, not current assets or performance.
Where is First Eagle Value in Biotechnology Fund (QP), LP based?
First Eagle Value in Biotechnology Fund (QP), LP is based in New York, New York.
When did First Eagle Value in Biotechnology Fund (QP), LP launch?
First Eagle Value in Biotechnology Fund (QP), LP reports its first sale in Sep 2005.
Size compared with every hedge fund
Raised more than 48% of the 2,525 hedge funds based in New York, and more than 51% of all 10,146 that report sales.